[HTML][HTML] Outcomes of the 340B Drug Pricing Program: A Scoping Review

RP Knox, J Wang, WB Feldman… - JAMA Health …, 2023 - jamanetwork.com
Importance The 340B Drug Pricing Program requires manufacturers to offer discounted drug
prices to support safety net hospitals and clinics (covered entities) providing care to low …

Outcomes of the 340B Drug Pricing Program: A Scoping Review

RP Knox, J Wang, WB Feldman… - JAMA health …, 2023 - pubmed.ncbi.nlm.nih.gov
Importance The 340B Drug Pricing Program requires manufacturers to offer discounted drug
prices to support safety net hospitals and clinics (covered entities) providing care to low …

[HTML][HTML] Outcomes of the 340B Drug Pricing Program: A Scoping Review

RP Knox, J Wang, WB Feldman… - JAMA Health …, 2023 - ncbi.nlm.nih.gov
Outcomes of the 340B Drug Pricing Program - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Outcomes of the 340B Drug Pricing Program: A Scoping Review

RP Knox, J Wang, WB Feldman… - JAMA Health …, 2023 - jamanetwork.com
Importance The 340B Drug Pricing Program requires manufacturers to offer discounted drug
prices to support safety net hospitals and clinics (covered entities) providing care to low …

Outcomes of the 340B Drug Pricing Program: A Scoping Review.

RP Knox, J Wang, WB Feldman, AS Kesselheim… - JAMA Health …, 2023 - europepmc.org
Outcomes of the 340B Drug Pricing Program: A Scoping Review. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Outcomes of the 340B Drug Pricing Program: A Scoping Review.

RP Knox, J Wang, WB Feldman, AS Kesselheim… - JAMA Health …, 2023 - europepmc.org
Outcomes of the 340B Drug Pricing Program: A Scoping Review. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …